Sentence and cancer type
Showing 301-320 of 577 items.
SentenceCancertype
A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?. None
Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases. None
Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF. None
The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. None
Glucocorticoids differentially inhibit expression of the RET proto-oncogene. None
A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease. None
Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes. None
Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells. None
Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation. None
Sp1 and Sp3 transactivate the RET proto-oncogene promoter. None
The RET proto-oncogene in human cancers. None
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. None
A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis. None
cDNA sequence and genomic structure of the rat RET proto-oncogene. None
A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys-->Arg). None
Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein. None
Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1. None
Three novel mutations in the RET proto-oncogene. None
Genomic organisation of the mouse Ret proto-oncogene. None
Cancers connected with mutations in RET proto-oncogene. None